Shandong Rike Chemical Co.,LTD. (SHE:300214)
China · Delayed Price · Currency is CNY 9.10
+0.87 (10.57%)
May 6, 2026, 3:14 PM CST
SHE:300214 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 3,723 | 3,742 | 3,478 | 2,522 | 2,707 | 2,773 |
Other Revenue | - | - | 40.16 | 15.58 | 52.25 | - |
| 3,723 | 3,742 | 3,518 | 2,538 | 2,760 | 2,773 | |
Revenue Growth (YoY) | -3.13% | 6.35% | 38.64% | -8.04% | -0.48% | 21.91% |
Cost of Revenue | 3,443 | 3,485 | 3,365 | 2,315 | 2,395 | 2,398 |
Gross Profit | 280.47 | 257.12 | 153.45 | 222.94 | 364.13 | 374.43 |
Selling, General & Admin | 147.84 | 145.75 | 122.45 | 80.84 | 72.9 | 81.88 |
Research & Development | 46.16 | 47.56 | 40.36 | 41 | 39.84 | 24.49 |
Other Operating Expenses | 9.66 | 9.87 | 23.16 | 15.2 | 17.97 | 20.12 |
Operating Expenses | 203.66 | 203.19 | 206.71 | 140.47 | 141.28 | 131.12 |
Operating Income | 76.81 | 53.93 | -53.26 | 82.47 | 222.85 | 243.31 |
Interest Expense | - | - | -35.82 | -5.09 | -0.21 | -0.57 |
Interest & Investment Income | 2.44 | 0.94 | 5.57 | 19.25 | 12.47 | 8.54 |
Currency Exchange Gain (Loss) | - | - | 6.83 | 5.03 | 20.6 | -5.69 |
Other Non Operating Income (Expenses) | -55.83 | -53.8 | -3.04 | -1.16 | -0.9 | -0.75 |
EBT Excluding Unusual Items | 23.42 | 1.08 | -79.72 | 100.5 | 254.8 | 244.84 |
Gain (Loss) on Sale of Investments | - | - | - | 0.88 | 1.18 | 0.72 |
Gain (Loss) on Sale of Assets | 6.98 | 3.86 | -0.24 | -5.63 | -11.74 | 0.09 |
Asset Writedown | -17.85 | -9.1 | -16.11 | -0.06 | - | -0.8 |
Other Unusual Items | - | - | 5.08 | -0.25 | -2.14 | -1.8 |
Pretax Income | 12.56 | -4.16 | -90.99 | 95.44 | 242.1 | 243.05 |
Income Tax Expense | 32.97 | 30.91 | -23.46 | 11.11 | 45.7 | 52.88 |
Earnings From Continuing Operations | -20.42 | -35.07 | -67.52 | 84.34 | 196.4 | 190.17 |
Minority Interest in Earnings | 1.42 | 5.36 | -0.64 | 0.3 | 0.1 | - |
Net Income | -19 | -29.71 | -68.16 | 84.63 | 196.5 | 190.17 |
Net Income to Common | -19 | -29.71 | -68.16 | 84.63 | 196.5 | 190.17 |
Net Income Growth | - | - | - | -56.93% | 3.33% | -8.15% |
Shares Outstanding (Basic) | 495 | 495 | 454 | 470 | 468 | 405 |
Shares Outstanding (Diluted) | 495 | 495 | 454 | 470 | 468 | 405 |
Shares Change (YoY) | 8.93% | 8.96% | -3.36% | 0.50% | 15.63% | -4.24% |
EPS (Basic) | -0.04 | -0.06 | -0.15 | 0.18 | 0.42 | 0.47 |
EPS (Diluted) | -0.04 | -0.06 | -0.15 | 0.18 | 0.42 | 0.47 |
EPS Growth | - | - | - | -57.14% | -10.64% | -4.08% |
Free Cash Flow | -2.89 | -30.83 | -785.84 | -735.35 | 15.86 | -64.83 |
Free Cash Flow Per Share | -0.01 | -0.06 | -1.73 | -1.56 | 0.03 | -0.16 |
Dividend Per Share | - | - | - | 0.040 | 0.060 | 0.076 |
Dividend Growth | - | - | - | -33.33% | -21.05% | -10.59% |
Gross Margin | 7.53% | 6.87% | 4.36% | 8.79% | 13.20% | 13.50% |
Operating Margin | 2.06% | 1.44% | -1.51% | 3.25% | 8.08% | 8.77% |
Profit Margin | -0.51% | -0.79% | -1.94% | 3.33% | 7.12% | 6.86% |
Free Cash Flow Margin | -0.08% | -0.82% | -22.34% | -28.98% | 0.57% | -2.34% |
EBITDA | 89.78 | 69.95 | -25.05 | 90.44 | 298.01 | 318.1 |
EBITDA Margin | 2.41% | 1.87% | -0.71% | 3.56% | 10.80% | 11.47% |
D&A For EBITDA | 12.97 | 16.02 | 28.21 | 7.97 | 75.17 | 74.79 |
EBIT | 76.81 | 53.93 | -53.26 | 82.47 | 222.85 | 243.31 |
EBIT Margin | 2.06% | 1.44% | -1.51% | 3.25% | 8.08% | 8.77% |
Effective Tax Rate | 262.55% | - | - | 11.64% | 18.88% | 21.76% |
Revenue as Reported | - | - | 3,518 | 2,538 | 2,760 | 2,773 |
Advertising Expenses | - | - | 1.17 | 0.59 | 0.6 | 0.55 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.